Physician profile
James Bradley
NPI 1487626149
$5,214,611.35
in general payments reported to CMS, 2019-2025
12 companies · $1.2M in 2025
The $1.2M reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258K · 2020: $233K · 2021: $452K · 2022: $843K · 2023: $1.1M · 2024: $1.2M · 2025: $1.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3.3M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $84K · Consulting Fee: $25K · Food and Beverage: $2,796 · Travel and Lodging: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,316,626.19 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83,585.00 |
| Consulting Fee | $25,110.00 |
| Food and Beverage | $2,795.69 |
| Travel and Lodging | $244.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,191,057.28 | 2019-2025 | Arthrex |
| Djo, LLC | $21,513.40 | 2019-2023 | |
| Reel Surgical, INC. | $1,304.29 | 2021 | |
| Exactech, INC. | $246.77 | 2023 | |
| Aesculap Biologics, LLC | $118.10 | 2019 | |
| Alpha Orthopedic Systems | $116.64 | 2021 | |
| Cgg Medical INC | $102.27 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.53 | 2024-2025 | Caplyta |
| Maruho Medical, INC. | $47.40 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.92 | 2025 | |
| Biotissue Holdings INC. | $16.25 | 2021 | |
| Amniox Medical, INC. | $2.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.